A U.S. Agency for International Development funding freeze in January forced the closure of India’s Mitr Clinic, the country’s first transgender healthcare facility, disrupting critical services for a vulnerable population.
Six months later, the clinic has reopened as Sabrang Clinic, reviving access to essential care for the transgender community.
Major Indian corporations, including some of the nation’s largest multinationals, stepped up with substantial financial support. Their backing has enabled Sabrang Clinic to resume its mission of delivering specialized, stigma-free medical services.
The former Mitr Clinic on May 2 reopened as the Sabrang Clinic. YR Gaitonde Center for AIDS Research and Education, an HIV/AIDS service organization, manages the facility.
The Sabrang Clinic sparked controversy in the U.S. when U.S. Sen. John Kennedy (R-La.) in February denounced its USAID funding, arguing that American taxpayer dollars should not support trans healthcare initiatives abroad. President Donald Trump amplified the criticism, labeling the agency’s spending on such programs as “wasteful” and aligning with his administration’s broader push to curb federal support for gender-affirming care. White House press secretary Karoline Leavitt further fueled the debate, citing the clinic’s funding as part of a pattern of USAID’s “radical” expenditures, while House Speaker Mike Johnson (R-La.) echoed the sentiment, decrying similar international projects as misaligned with American priorities.
Elon Musk, who until May led the Department of Government Efficiency, added to the controversy surrounding the clinic.
“That’s what American tax dollars were funding,” he said in a Feb. 28 X post.
His remark, made before his departure from the Trump-Vance administration, spotlighted the clinic’s USAID support, intensifying debates over its role in delivering trans healthcare in India.
The Washington Blade on Feb. 27 detailed how the USAID funding freeze crippled Mitr Clinic’s operations, spotlighting the broader fallout for South Asian LGBTQ organizations.
The Blade noted the clinic, a vital resource for trans healthcare in India, faced abrupt closure alongside groups in Nepal, Bangladesh, and Pakistan, as the freeze slashed support for programs addressing HIV/AIDS, mental health, and gender-based violence, leaving thousands without access to essential services.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and USAID in 2021 launched Program ACCELERATE, spearheaded by the Johns Hopkins University School of Medicine, to establish Mitr Clinic in Hyderabad in Telangana State. As India’s first comprehensive healthcare center for the trans community, the facility offered tailored medical services, including HIV/AIDS treatment and mental health support, filling a critical gap in the region’s healthcare landscape.
Sabrang Clinic serves a critical role for India’s estimated one million trans people, a population facing a disproportionate HIV/AIDS burden.
A 2019 Reuters report noted a 3.1 percent HIV prevalence among trans people, translating to roughly 31,000 individuals living with the virus, compared to the national adult rate of 0.26 percent. Similarly, a 2021 UNAIDS report cited a 3.8 percent prevalence, suggesting approximately 38,000 trans people with HIV/AIDS.
Internal reports indicate the clinic since it opened in 2021 has served more than 3,000 patients. It has become a model of community-led care that fosters trust and addresses the unique health needs of trans people in Hyderabad.
When USAID funding cuts forced Sabrang Clinic’s closure, scores of people and LGBTQ community members in Hyderabad were left without access to reliable, stigma-free healthcare. Undaunted, the clinic’s trans-led team pivoted to virtual consultations and medication delivery, sustaining critical support for patients until corporate funding revived operations.
Tata Trusts, a philanthropic arm of India’s Tata conglomerate, in April pledged to fund the clinic for three years.
The Hindu, a leading Indian English-language newspaper, reported the trust committed approximately $18 per person a year to sustain the clinic’s operations. This contrasts with the earlier USAID program, which had provided about $23 per person each year.
Tata Trusts covers the salaries of Sabrang Clinic’s core medical staff, while its leadership positions are jointly funded by Tata and the clinic’s parent organization. The clinic is now pursuing partnerships with additional donors to expand its trans-focused healthcare services.
“We are elated to continue this service, as we have always believed that sexual minorities deserve respect and their right to self-expression,” said YRGCARE Chief Operating Officer A.K. Srikrishnan. “That’s why we launched Mitr Clinic under Project ACCELERATE in 2021, and it operated until January 2025. The Trump administration’s USAID funding withdrawal forced a shutdown, but we have no comment on that. Fortunately, with great vigor, we secured support from Tata Trusts to sustain Sabrang Clinic. The name change to Sabrang, also called ‘Help for All,’ was simply to reposition the brand, with no deeper logic attached.”
Srikrishnan told the Blade that YRGCARE will aim to raise additional crowdfunding and support if the current funding proves insufficient to maintain the same level of services at the clinic. Srikrishnan also thanked Tata Trusts for its support.
“We want to expand it throughout the country given the choice,” said Srikrishnan. “If someone were to tell us, ‘Can you run it across the country?’ we would certainly love to do it.”
“Sexual minorities are a reality, and however much someone wishes them away, they exist and need to exist with the respect and rights they deserve,” added Srikrishnan. “We do not differentiate between local and foreign contributions; when we needed it most, Tata Trusts stepped in and helped. So we are certainly grateful to them.”
Washington Blade courtesy of the National LGBTQ Media Association.
